Home Search
cannabinoids - search results
If you're not happy with the results, please do another search
UK Cannabis Industry – the next Scottish Whisky
Nick Morland, Tenacious Labs CEO, All-Party Parliamentary Group for CBD Products Secretariat, Jersey Cannabis Services Advisory Board Chair, writes about the UK Cannabis Industry – could this be the next Scottish Whisky?
Do labels efficiently tell you what’s in your weed strain?
Research finds that labels on weed often fail to adequately reflect products' chemical make-up and components of the weed strain.
Medical cannabis & the future of cancer treatments
Dr Stephen Barnhill MD, CEO of Apollon Formularies Plc, examines medical cannabis and the future of cancer treatments across the UK and the European healthcare sectors.
Are animal CBD products safe?
Suzette Smiley-Jewell, PhD & Pamela J. Lein, PhD from the University of California, Davis, explore the extent to which animal CBD products are safe
The burden of psychogenic nonepileptic seizures on physicians and patients
The importance of increasing awareness of nonepileptic spells among physicians, patients, families and the general public
Medical cannabis-based treatments: Research, production & distribution
Prof Trevor M Jones charts the priorities for research and development, production and distribution of medical cannabis-based treatments
How can hemp compounds block the COVID-19 virus infection?
Research demonstrates the ability to prevent COVID-19 from entering human cells through cannabinoid acids binding to a SARS-CoV-2 protein, blocking infection from the virus.
Researching CBD oil for depression
CBD has wide-ranging benefits, but what about its effects on depression? Here, we find out what the research shows from Oils by Simpson of 2012.
How does cannabis use affect sleep duration?
Recent cannabis use has been shown to affect extremes of nightly sleep duration, being either less than six hours or more than nine hours, with more intense patterns among heavier users.
Contemporary treatments for epilepsy
Dr Arun Swaminathan, Assistant Professor of Neurology and Epilepsy at the University of Nebraska, explores the contemporary power of neurostimulation in treating epilepsy.
The evolving role of telemedicine in epilepsy care
Arun Swaminathan MD, Assistant Professor of Neurology and Epilepsy at the University of Nebraska explores the challenges and benefits of telemedicine following the COVID-19 pandemic.
TIGRR: Is it a wonderful thing for the UK’s Cannabis Industry?
BCL Solicitors LLP ask if a new report should put a spring in the step of UK businesses with an interest in medicinal cannabis and cannabidiol (CBD).
CBD for arthritis: What the research shows
CBD has shown benefits for many health conditions, including arthritis. Here’s what the research shows.
CBD oil for pain: What the research shows
Oils by Simpson of 2012 supplies organic full-spectrum CBD cannabis oil products. CBD oil is popular and commonly used for its potent therapeutic benefits, but what about its effect on pain? Here’s what the research shows.
Will 2021 see the UK’s cannabis industry bloom?
John Binns & David Hardstaff from BCL Solicitors LLP, reveal if 2021 will be the year that sees the UK’s cannabis industry bloom.
CBD oil for ADHD: What the research shows
CBD oil is popular for its wide-ranging therapeutic benefits, but what about its effects on ADHD? Here’s what the research shows.
Cannabis as a treatment for COVID-19
Kevin William Simpson, CEO and Founder of OilsBySimpson, tells us about the growing evidence around cannabis as a treatment for COVID-19.
CBD Novel Foods in the UK
Lead Scientific Officer at Always Pure Organics Andrew Megahy, explains how the UK is now in a prime position for the future of CBD use, due to the Novel Foods Application.
The changing perspective of psychedelic drugs with a history of abuse
Jason W. Loxterkamp and Pamela J. Lein from University of California, Davis, explore the therapeutic potential of psychedelic drugs in patients with psychiatric disorders.
Cannabidiol, skin homeostasis and acne
Dr. Christian Löfke, researcher and product developer at BioBloom in Austria explains the potential of CBD and cannabinoids for skin care.